{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T06:36:07Z","timestamp":1790922967358,"version":"4.1.0"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T00:00:00Z","timestamp":1559001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["AR 645\/3-1"],"award-info":[{"award-number":["AR 645\/3-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB841"],"award-info":[{"award-number":["SFB841"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.01065","type":"journal-article","created":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T00:39:59Z","timestamp":1559003999000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["Inflammatory Phenotype of Intrahepatic Sulfatide-Reactive Type II NKT Cells in Humans With Autoimmune Hepatitis"],"prefix":"10.3389","volume":"10","author":[{"given":"Marcial","family":"Sebode","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Wigger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Filpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutz","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f6ren","family":"Weidemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Till","family":"Krech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Weiler-Normann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moritz","family":"Peiseler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Hartl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Tolosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Herkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Schramm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ansgar W.","family":"Lohse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philomena","family":"Arrenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,5,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.bpg.2011.09.009","article-title":"Pathogenesis of autoimmune hepatitis","volume":"25","author":"Liberal","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL clinical practice guidelines: autoimmune hepatitis","volume":"63","year":"2015","journal-title":"J Hepatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/0270-9139(91)92567-R","article-title":"Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors","volume":"13","author":"Donaldson","year":"1991","journal-title":"Hepatology."},{"key":"B4","doi-asserted-by":"publisher","first-page":"548","DOI":"10.3389\/fimmu.2018.00548","article-title":"CD1d-restricted type II NKT cells reactive with endogenous hydrophobic peptides","volume":"9","author":"Nishioka","year":"2018","journal-title":"Front Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1172\/JCI31602","article-title":"Type II NKT cell-mediated anergy induction in type I NKT cells prevents inflammatory liver disease","volume":"117","author":"Halder","year":"2007","journal-title":"J Clin Invest."},{"key":"B6","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1053\/j.gastro.2010.10.003","article-title":"Sulfatide-mediated activation of type II natural killer T cells prevents hepatic ischemic reperfusion injury in mice","volume":"140","author":"Arrenberg","year":"2011","journal-title":"Gastroenterology."},{"key":"B7","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/imm.12247","article-title":"Different subsets of natural killer T cells may vary in their roles in health and disease","volume":"142","author":"Kumar","year":"2014","journal-title":"Immunology."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.3389\/fimmu.2018.01969","article-title":"Type II NKT cells: an elusive population with immunoregulatory properties","volume":"9","author":"Singh","year":"2018","journal-title":"Front Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nature05907","article-title":"CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor","volume":"448","author":"Borg","year":"2007","journal-title":"Nature."},{"key":"B10","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.smim.2009.10.004","article-title":"Antigen recognition by CD1d-restricted NKT T cell receptors","volume":"22","author":"Godfrey","year":"2010","journal-title":"Semin Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/cmi.2015.115","article-title":"NKT cell subsets as key participants in liver physiology and pathology","volume":"13","author":"Bandyopadhyay","year":"2016","journal-title":"Cell Mol Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nri2904","article-title":"Presumed guilty: natural killer T cell defects and human disease","volume":"11","author":"Berzins","year":"2011","journal-title":"Nat Rev Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"10984","DOI":"10.1073\/pnas.1000576107","article-title":"Oligoclonality and innate-like features in the TCR repertoire of type II NKT cells reactive to a beta-linked self-glycolipid","volume":"107","author":"Arrenberg","year":"2010","journal-title":"Proc Natl Acad Sci USA."},{"key":"B14","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/ni.2371","article-title":"Type II natural killer T cells use features of both innate-like and conventional T cells to recognize sulfatide self antigens","volume":"13","author":"Girardi","year":"2012","journal-title":"Nat Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1084\/jem.20031389","article-title":"Prevention of autoimmunity by targeting a distinct, non-invariant CD1d-reactive T cell population reactive to sulfatide","volume":"199","author":"Jahng","year":"2004","journal-title":"J Exp Med."},{"key":"B16","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/hep.1840120408","article-title":"Hepatocyte plasma membrane glycosphingolipid reactive with sera from patients with autoimmune chronic active hepatitis: its identification as sulfatide","volume":"12","author":"Toda","year":"1990","journal-title":"Hepatology."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1194\/jlr.R026682","article-title":"Role of sulfatide in normal and pathological cells and tissues","volume":"53","author":"Takahashi","year":"2012","journal-title":"J Lipid Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"4580","DOI":"10.4049\/jimmunol.1400699","article-title":"Recognition of lysophosphatidylcholine by type II NKT cells and protection from an inflammatory liver disease","volume":"193","author":"Maricic","year":"2014","journal-title":"J Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1182\/blood-2008-04-149831","article-title":"Inflammation-associated lysophospholipids as ligands for CD1d-restricted T cells in human cancer","volume":"112","author":"Chang","year":"2008","journal-title":"Blood."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1073\/pnas.1220601110","article-title":"Recognition of microbial and mammalian phospholipid antigens by NKT cells with diverse TCRs","volume":"110","author":"Tatituri","year":"2013","journal-title":"Proc Natl Acad Sci USA."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1182\/blood-2014-09-600270","article-title":"Type II NKT-TFH cells against gaucher lipids regulate B-cell immunity and inflammation","volume":"125","author":"Nair","year":"2015","journal-title":"Blood."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1002\/hep.27632","article-title":"Inhibition of type I natural killer T cells by retinoids or following sulfatide mediated activation of type II natural killer T cells attenuates alcoholic liver disease in mice","volume":"61","author":"Maricic","year":"2015","journal-title":"Hepatology."},{"key":"B23","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.jhep.2017.05.024","article-title":"Crosstalk between type II NKT cells and T cells leads to spontaneous chronic inflammatory liver disease","volume":"67","author":"Weng","year":"2017","journal-title":"J Hepatol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/hep.23792","article-title":"A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis","volume":"52","author":"Ferri","year":"2010","journal-title":"Hepatology."},{"key":"B25","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.humimm.2004.03.004","article-title":"Simultaneous expression of Th1 cytokines and IL-4 confers severe characteristics to type I autoimmune hepatitis in children","volume":"65","author":"Cher\u00f1avsky","year":"2004","journal-title":"Hum Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology."},{"key":"B27","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0895-4356(93)90101-6","article-title":"Causality assessment of adverse reactions to drugs\u2013I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries","volume":"46","author":"Danan","year":"1993","journal-title":"J Clin Epidemiol."},{"key":"B28","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/0895-4356(93)90102-7","article-title":"Causality assessment of adverse reactions to drugs\u2013II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge","volume":"46","author":"Benichou","year":"1993","journal-title":"J Clin Epidemiol."},{"key":"B29","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J Hepatol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jhep.2012.02.029","article-title":"FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency","volume":"57","author":"Peiseler","year":"2012","journal-title":"J Hepatol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"316","DOI":"10.3389\/fimmu.2015.00316","article-title":"Type II NKT Cells in inflammation, autoimmunity, microbial immunity, and cancer","volume":"6","author":"Marrero","year":"2015","journal-title":"Front Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.4049\/jimmunol.1101390.","article-title":"CD4(+) type II NKT cells mediate ICOS and programmed death-1-dependent regulation of type 1 diabetes","volume":"188","author":"Kadri","year":"2012","journal-title":"J Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2015.06.025","article-title":"Tissue-specific distribution of iNKT cells impacts their cytokine response","volume":"43","author":"Lee","year":"2015","journal-title":"Immunity."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.4049\/jimmunol.1601399","article-title":"Type II NKT cells and their emerging role in health and disease","volume":"198","author":"Dhodapkar","year":"2017","journal-title":"J Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1002\/hep.23599","article-title":"Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease","volume":"51","author":"Syn","year":"2010","journal-title":"Hepatology."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.4049\/jimmunol.171.4.1775","article-title":"NKT cells from normal and tumor-bearing human livers are phenotypically and functionally distinct from murine NKT cells","volume":"171","author":"Kenna","year":"2003","journal-title":"J Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1002\/eji.201242531.","article-title":"The majority of CD1d-sulfatide-specific T cells in human blood use a semiinvariant V\u03b41 TCR","volume":"42","author":"Bai","year":"2012","journal-title":"Eur J Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1136\/gutjnl-2013-305671.","article-title":"IL-13R\u03b12-bearing, type II NKT cells reactive to sulfatide self-antigen populate the mucosa of ulcerative colitis","volume":"63","author":"Fuss","year":"2014","journal-title":"Gut."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1002\/eji.201747334","article-title":"IL13Ralpha2 expression identifies tissue-resident IL-22-producing PLZF(+) innate T cells in the human liver","volume":"48","author":"Paquin-Proulx","year":"2018","journal-title":"Eur J Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1053\/j.gastro.2008.02.037","article-title":"Critical role for CD1d-restricted invariant NKT cells in stimulating intrahepatic CD8 T-cell responses to liver antigen","volume":"134","author":"Sprengers","year":"2008","journal-title":"Gastroenterology."},{"key":"B41","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1146\/annurev.immunol.25.022106.141711","article-title":"The biology of NKT cells","volume":"25","author":"Bendelac","year":"2007","journal-title":"Annu Rev Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.jhep.2012.11.010","article-title":"Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis","volume":"58","author":"Weiler-Normann","year":"2013","journal-title":"J Hepatol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1007\/s00535-015-1060-5","article-title":"Invariant natural killer T cell deficiency leads to the development of spontaneous liver inflammation dependent on \u03b3\u03b4T cells in mice","volume":"50","author":"Nishio","year":"2015","journal-title":"J Gastroenterol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jaut.2013.07.003","article-title":"The role of natural killer cells in autoimmune liver disease: a comprehensive review","volume":"46","author":"Hudspeth","year":"2013","journal-title":"J Autoimmun."},{"key":"B45","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1053\/j.gastro.2011.10.030","article-title":"Dysregulation of CD1d-restricted type II natural killer T cells leads to spontaneous development of colitis in mice","volume":"142","author":"Liao","year":"2012","journal-title":"Gastroenterology."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1172\/JCI19836","article-title":"Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis","volume":"113","author":"Fuss","year":"2004","journal-title":"J Clin Invest."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.4049\/jimmunol.173.2.1417","article-title":"Production of profibrotic cytokines by invariant NKT cells characterizes cirrhosis progression in chronic viral hepatitis","volume":"173","author":"De Lalla","year":"2004","journal-title":"J Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1002\/hep.27840","article-title":"The biliary epithelium presents antigens to and activates natural killer T cells","volume":"62","author":"Schrumpf","year":"2015","journal-title":"Hepatology."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1053\/gast.2002.36020","article-title":"Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer","volume":"123","author":"Kita","year":"2002","journal-title":"Gastroenterology."},{"key":"B50","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/hep.22052","article-title":"Natural killer T cells exacerbate liver injury in a transforming growth factor beta receptor ii dominant-negative mouse model of primary biliary cirrhosis","volume":"47","author":"Chuang","year":"2008","journal-title":"Hepatology."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01065\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T00:40:03Z","timestamp":1559004003000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01065\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,28]]},"references-count":50,"alternative-id":["10.3389\/fimmu.2019.01065"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.01065","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,28]]},"article-number":"1065"}}